Lee B, Mynard N, Nasar A, Villena-Vargas J, et al. Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trial. J Thorac Cardiovasc Surg 2022 Aug 6. pii: S0022-5223(22)00804.
PMID: 36028357